Childhood Cancer and Antiemetic Use in Pregnancy
Author Information
Author(s): P.A. McKinney, R.A. Cartwright, C.A. Stiller, P.A. Hopton, J.R. Mann, J.M. Birch, A.L. Hartley, J.A.H. Waterhouse, H.E. Johnston
Primary Institution: Yorkshire Regional Cancer Organisation
Hypothesis
Does the ingestion of antiemetics during pregnancy increase the risk of childhood cancer?
Conclusion
The study found that antiemetic ingestion during pregnancy does not significantly increase the risk of childhood cancer in the exposed fetus.
Supporting Evidence
- Separate analyses suggested that antiemetic ingestion does not increase the risk of childhood malignant disease.
- No dose-response relationship was evident.
- The lack of significant relative risks held for diagnostic sub-groups.
- Medical records showed a similar percentage of mothers taking antiemetics for cases and controls.
Takeaway
Moms taking certain nausea medications while pregnant don't seem to make their kids more likely to get cancer.
Methodology
The study analyzed data from interviews and medical records of 555 mothers of children with cancer and 1110 mothers of matched control children.
Potential Biases
There may be recall bias in self-reported data from mothers regarding drug ingestion.
Limitations
The study may not account for all potential confounding factors related to childhood cancer.
Participant Demographics
Mothers of children under 15 years of age, with a control group matched for age and sex.
Statistical Information
P-Value
0.10
Confidence Interval
95% confidence interval 0.23, 0.94
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website